Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter

PHASE4CompletedINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

February 29, 2008

Conditions
Atrial Flutter
Interventions
DEVICE

RF energy delivery for treatment of Typical Atrial flutter

Navistar ThermoCool catheter

Trial Locations (23)

19104

University of Pennsylvania, Philadelphia

21201

University of Maryland, Baltimore

22042

INOVA Research Center, Falls Church

23219

Virginia Commonwealth University, Richmond

27710

Duke University Medical Center, Durham

29425

Medical University of South Carolina, Charleston

32611

University of Florida, Gainsville

32803

Florida Hospital, Orlando

33031

Memorial Regional Hospital, Hollywood

35294

University of Alabama, Birmingham, Birmingham

40503

Central Baptist Hospital, Lexington

46060

The Care Group LLC, St. Vincent Hospital and Health Care Center, Inc., Indianapolis

48236

St. John Hospital and Medical Center, Detroit

55416

Park Nicollet Institute, Minneapolis

60637

University of Chicago, Chicago

73104

University of Oklahoma, Health Sciences Center, Oklahoma City

77030

Texas Heart Institute, Houston

85251

Arizona Arrhythmia Consultants, Scottsdale

90017

Good Samaritan Hospital, Los Angeles

90404

Pacific Heart Institute, Santa Monica

04102

Maine Medical Center, Portland

02114

Massachusetts General Hospital, Boston

05401

University of Vermont, College of Medicine, Burlington

All Listed Sponsors
lead

Biosense Webster, Inc.

INDUSTRY

NCT00318565 - Catheter Evaluation for Endocardial Ablation in Patients With Typical Atrial Flutter | Biotech Hunter | Biotech Hunter